← Eichor
Study identifier: NCT06531681 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)

Condition: Overall Response Rate · Oncology · Radiation Toxicity  ·  Sponsor: The Second Affiliated Hospital of Hainan Medical University

PhaseN/A
Planned participants3000
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

Aim to observe the application of MR-Linac for precision radiotherapy of tumours, analyse its therapeutic effect, toxic and side effects,Characteristics of dosimetric parameters etc.

This description comes directly from the study's public registry record.

Talk to the study team

junnv xu, doctor  ·  18208946196  ·  xujunnv@sina.com

yuecan zeng, doctor  ·  19946610752  ·  wellyy2005@hainmc.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

The Second Affiliated Hospital of Hainan Medical UniversityHaikou, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06531681